Clariane's Stock Climbs 3.43% to €4.34, Marking a +12% Over Three Months

A Session in the Green Propelling the Stock into Potential Overbought Territory

Clariane's stock gains 3.43% to €4.34 in mid-afternoon, ranking among the highest rises in the SBF 120. The broader index itself is up by 0.83% during the session, placing the stock well above the average performance of the Parisian market. Over the week, the increase reaches 2.65%. The stock is trading in the upper part of the Bollinger Bands, at 96% of the range, close to the upper limit at €4.37. This position reflects the acceleration of the movement that began in mid-April: the stock is 8.3% above its 20-day moving average (€4.01) and 8.8% above its 200-day moving average (€3.99). The RSI at 60 remains neutral, without marked excess. The resistance identified at €4.29 was exceeded during the session, technically opening the way towards the top of the Bollinger Bands. Meanwhile, Emeis, another sector player, gains 3.46% at the same time.

Bond Refinancing and Organic Growth in Q1 Frame the Trajectory

The group posted an organic growth of 4.9% in the first quarter of 2026, reaching a revenue of €1.336 billion, with confirmation of the objectives for 2023-2026 and 2025-2028. A few days later, on April 28, Clariane launched an additional senior bond issue of €230 million maturing in 2031, bearing interest at 6.875%, aimed at refinancing its hybrid debt. These two operations have supported the gradual recovery of the stock, which crossed back above its 200-day average at the beginning of May. The annual general meeting was held on May 12. The next appointment set by the financial calendar is the publication of the first half of 2026 results, expected on July 29. Over one year, the stock now shows a progression of 10.4%.